Novartis Pharma GmbH

Novartis Pharma GmbH is a global pharmaceutical manufacturer and biotech healthcare company headquartered in Nuremberg, Germany, specializing in innovative prescription medicines and advanced therapeutics. The company focuses on core therapeutic areas including cardiovascular, renal, and metabolic diseases, immunology, neuroscience, and oncology, addressing serious unmet medical needs worldwide. Leveraging cutting-edge technology platforms, Novartis develops biotherapeutics, xRNA therapies, radioligand therapies, gene therapies, and cell therapies to transform patient treatment. Serving healthcare professionals, hospitals, pharmacies, and patients, the organization provides breakthrough prescription drugs and comprehensive medical information services. Through extensive clinical research and strategic partnerships, Novartis advances drug discovery and development across major disease areas including breast cancer, prostate cancer, and multiple sclerosis. The enterprise operates state-of-the-art research, development, and manufacturing facilities across Germany and international markets. With a dedicated workforce driving scientific innovation, Novartis delivers life-changing medicines that extend and improve lives globally.